The board has recommended a final dividend payout of Rs 1.50 per share. In FY23, Biocon’s revenue grew almost 37% to Rs 11,174 crore, while its net profit fell nearly 29% to Rs 463 crore. The biosimilars business segment more than doubled its year-on-year revenue to INR2,102 crore in Q4 2022.
Union Bank of India approves plan to raise up to Rs 20,000 crore via long-term bonds
Union Bank of India will raise funds through bond issuances. The bank’s committee approved long-term bonds worth twenty thousand crore rupees for infrastructure and affordable
March 16, 2026